Page 53 - MemoriaDEM-Eng
P. 53




www.ciberdem.org



Most relevant • MaRtín-núñez GM, CabReRa-MuleRo R, Rojo-MaRtínez G, GóMez-zuMaqueRo jM, ChaVes Fj, 
de MaRCo G et al.. Polymorphisms in the SCD1 gene are associated with indices of 
scientific 
stearoyl CoA desaturase activity and obesity: a prospective study.Mol Nutr Food Res. 
articles
2013 Dec;57(12):2177-84.

• G-R C, R-M G, s F, G-F e, V j, V ja 
utIéRRezePIsoojoaRtínezoRIGueRaRCíauentesendRellázquez
et al.. Factors affecting levels of urinary albumin excretion in the general population 
of Spain: the [email protected] study.Clin Sci (Lond). 2013 Feb;124(4):269-77.

• M a, b b, b dj, dM la, G se, G R .. Interleukin-1 
oRanundyeCkeRIeGlIoItelManolandet al
antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double- 
blind, placebo-controlled trials.Lancet. 2013 Jun 1;381(9881):1905-15.


• CaMeRon Fj, de beauFoRt C, aanstoot hj, hoey h, lanGe k, Castano l et al.. Lessons from 
the Hvidoere International Study Group on childhood diabetes: be dogmatic about 

outcome and flexible in approach.Pediatr Diabetes. 2013 Nov;14(7):473-80.

• de beauFoRt Ce, lanGe k, swIFt PG, aMan j, CaMeRon F, Castano l et al.. Metabolic outcomes 
in young children with type 1 diabetes differ between treatment centers: the Hvidoere 

Study in Young Children 2009.Pediatr Diabetes. 2013 Sep;14(6):422-8.



• Participation in international projects on diabetes prevention, either nutritional 
Highlights
(TRIGR project-NIH 5U01HD040364-08) or about immunomodulation using an- 

tigens (Dyamid Project).

• Colaboration with the International Group of Pediatric Diabetes (Hvidore Group)

• Completion of Di@betes Study: study about the epidemiology of diabetes in 

Spain; completion of the Basque study about epidemiology of diabetes in the 
Basque Country (Basque Health Department GV2010111058)

• Participation in the Europen MEDIGENE Project (FP7-279171-1) about characte- 

rization of diabetes in Mediterranean populations.

• Development of projects about molecular characterization of monogenic diabe- 

tes (Basque Department of Education GV IT795-3; Basque Health Department 
GV 2010111185).


During the development of these projects, more than 16 articles have been pu- 
blished in several journals (i.e.: ,:Moran A, et al. Interleukin-1 antagonism in type 

1 diabetes of recent onset: two multicenter, randomized, double-blind, placebo- 
controlled trials. Lancet. 2013 Jun 1;381(9881):1905-15)








13
20
T 
OR
P
RE
L 
A
NU
N
 A
M /
E
D
ER
B
CI

53







   51   52   53   54   55